chrisvoncsefalvay/vaers-outcomes huggingface dataset:
had all my shots and still got shingles/suspected vaccination failure; Shingles; Worst pain ever; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 7-July-2022 Reporter's Comment: This case was received from interactive digital media. The patient had all his/her shots and still got shingles. The patient stated, worst pain ever-get the shot folks. Additional supportive information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
pt to this clinic for tx d/t adverse rxn;pt did not recv vax @ this clinics;pt exp skin rash on upper/lower extremities, fever & flushing;pt recv DPH prescription, calamine lotion & APAP for tx;
Describes the rash as hives; Woke up with rash on the lower half of her face and neck; Fever of 102F after 2nd dose; Severe reaction after 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Describes the rash as hives), VACCINATION COMPLICATION (Severe reaction after 2nd dose), RASH (Woke up with rash on the lower half of her face and neck) and PYREXIA (Fever of 102F after 2nd dose) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 004M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION COMPLICATION (Severe reaction after 2nd dose). On 23-Feb-2021, the patient experienced PYREXIA (Fever of 102F after 2nd dose). On 25-Feb-2021, the patient experienced URTICARIA (Describes the rash as hives) and RASH (Woke up with rash on the lower half of her face and neck). At the time of the report, URTICARIA (Describes the rash as hives), VACCINATION COMPLICATION (Severe reaction after 2nd dose), RASH (Woke up with rash on the lower half of her face and neck) and PYREXIA (Fever of 102F after 2nd dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Feb-2021, Body temperature: 102 (Inconclusive) 102 F.         No concomitant and treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-026651 (Patient Link).
Headaches 2 days to 5 days after the booster. They seemed like migraines. I felt sick and thought I was going to throw up from them. I have never had migraines before, but assume this is what they would feel like. Two of them, one on Monday morning, and the other Wednesday afternoon were the two worst headaches I've ever had.
Moderna 10/22/21, 12/15/21. Positive on 10/24/22
Information has been received from a health professional regarding a 70 year old male pt who in November 2003, was vaccinated with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. Subsequently in November 2003, the pt experienced injection site reactions which included injection site swelling, soreness and erythema. He was treated with Benadryl and cold compresses. As of 03DEC2003, the pt's adverse events abated and it was reported that the pt was "recently seen at the office for an abnormal CT scan". There was no product quality complaint involved. The reporter indicated that three other pts had similar experiences following exposure to pneumococcal 23v polysaccharide vaccine. Additional info has been requested.
No other adverse event involved; Nurse calls and states an expired dose of PNEUMOVAX 23 PFS was inadvertently given to a patient; Information has been received from a registered nurse reporting on a 74-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication.  On 09-JUL-2021, the patient was vaccinated inadvertently with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis, lot# S034299, expiry date 01-JUL-2021  (dose and route of administration were not reported). No other adverse event involved. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S034299; expirationdate: 01-JUL-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Itchy rash/hives onset later in the day on Saturday 11/6/2021 and persisted through the weekend and into the week. Went into my PCP office for a visit on Monday 11/8/2021 in regards to the rash. Unknown common source or cause of rash. Started on a step-down of the steroid prednisone for 8 days to see if rash/hives clears up. Rash/hives appear and disappear all over body (arms, legs, neck, chest and back).  Rash/hives beginning to get better after a day and a half on the steroid.
pt recv vax 25APR94 & that same day devel a 1-inch wide telangectasia on leg;sx were resolving;
4MAY93 p/receiving shots taken to ER because wouldn't stop crying, rt leg swollen, fever, spots around inject site; ER MD stated that had an allergic reaction to immun;
Same day post vax, the pt developed an injection site reaction characterized by tenderness and induration. The pt recovered.
Within 30 minutes I was very nauseous (10 on a scale of one to ten). Then headache started in frontal lobe area (reminds me of when I had covid in 2/2020 and doesn't respond to anything).  Slight itchiness. Lots of pain (widespread body pain not body aches). By 10 hours the pain was preventing sleep and the chills were causing shivering. Fever is steady between 101-102. I'm very itchy now (arms, chest, face, legs 6 on a scale of one to ten) with slight redness to chest/face. Briefly had pain with deep breaths but that has stopped. I've got major frequent urination (about every 30mins, not drinking much due to nausea). Shoulders are both hurting and stiff (not necessarily uncommon). I  literally feel worse than having covid and I had to call in to work.
Pt ran high fever, had extensive rash all over body, very cranky wouldn't eat, inject site red raised & hard-rash lasted 2 wks;
PEDIARIX given inadvertently @ same visit as PENTACEL.  Infant's mother aware.  Spoke to her 6/22, reports no adverse reactions, no site redness or swelling.
Patient started having swelling & redness under both eyes. Patient also broke out in a rash on her neck and chest. 7.5 ml of Benadryl was administered per Dr. Patient was kept in the office for 30 minutes for further evaluation and then was released.
Information has been received from a nurse referring to an unspecified number of patients of unknown age and gender. Patients' pertinent medical history or drug allergies were not reported. On unknown dates patients received improperly stored GARDASIL 9 (lot#, expiration date, strength, dose, frequency and route were unknown). The patient's concomitant medication was not reported. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
2 days post shot pt cannot lift up arm. Shot was uneventful not painful. But was placed in upper 1/3 of deltoid.
aggressively heave; full body sweating; Intense nausea; pain and soreness in the arm that received the vaccination; Incapacitated with violent vomiting continued to aggressively heave and would vomit yellow bile; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm left on 06Apr2021 at 16:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression on unknown dates. The patient was allergic to avocado (fruit allergy) and cinnamon (spice allergy). Concomitant medications included paracetamol (ACETAMINOPHEN), bupropion (BUPROPION XL), ethinylestradiol, norgestrel (CRYSELLE) and chlorcyclizine hydrochloride, pseudoephedrine hydrochloride (STAHIST AD) all taken from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 13:00 the patient experienced intense nausea to the point of being incapacitated with violent vomiting, after vomiting everything in the stomach, the patient continued to aggressively heave and vomited yellow bile, movement of any sort would trigger intense nausea and eventually vomiting, any solid, bland food was unable to stay down for longer than 5 minutes, vomiting was coupled with full body sweating despite having no fever and other negative effects included pain and soreness in the arm that received the vaccination. Severe symptoms lasted at least 12 hours, and less severe nausea continues. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events Intense nausea (nausea) to the point of being incapacitated with violent vomiting (vomiting). After vomiting everything in her stomach, she continued to aggressively heave (retching) and would vomit yellow bile (vomiting). Vomiting was coupled with full body sweating(hyperhidrosis) despite having no fever. Severe symptoms lasted at least 12 hours, and less severe nausea continues. Other negative effects included pain and soreness in the arm (pain in extremity) that received the vaccination were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
My arm has been hurting for 13 days straight.  The pain has also moved down my arm to my elbow and lower.  Hurts all the time, keeps me up at night.  Hurts to lift arm or raise it.  Got worse instead of better.
Patient received J&J vaccine at another facility (Health Department) on 3/9.  Patient was in route back home and developed facial flushing and increased heart rate.  patient presented to this reporters ED.  Pateint treated with Diphenhydramine 25mg IV, Lorazepam 0.5m po, ondansetron 8mg po and IV fluids.   Symptoms resolved.  further workup unremarkable.  patient discharged to home
has a white spot; This is a spontaneous report from a contactable consumer or other non hcp Pfizer. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced has white spot on an unspecified date. The reporter stated the site where her mom got the vaccine, has a white spot. States its not painful and that it was hard yesterday but today its normal. The outcome of event was unknown.  Follow-up attempts are completed. No further information is expected.
Approximately 15 days after the shot noticed large red patch where the shot had been administer. Was not there for at least 7 days after the shot. No itch, slight swelling.
100.4 fever, nausea, chills, vomiting early the first morning, aches/pains throughout body
Stated red face, tight feeling in chest within 30 minutes of vaccination. Gave self EPIPEN since he carries for life threatening bee allergy.
Vaccine triggered Guillian Barre Syndrome, 90% paralyzed from the waist down, hospitalized for 12 days, rehab hospital for 12 days Still doing out-patient rehab. Walking and doing daily activities, but with limited strength and stamina
Information has been received from a physician, through a company representative, concerning a 16 month old female who on 03/13/2002 at 15:25 was vaccinated with the first dose of MMR II vaccine, administered in the right thigh. Concomitant therapy, that same day and time, included the fourth dose of Infanrix, administered in the left thigh and the fourth dose of IPOL, administered in the right thigh. It was reported that the pt had a left ear infection, with no fever, at the time of vaccination. On 03/31/2002, the pt developed "significant" erythema and swelling involving the left forearm, wrist, and ankle. She also developed tenderness of the lower extremities. In addition, she developed swelling of the right lower extremity, but no erythema. Subsequently, the pt was hospitalized, that same day, for a duration of 8 days, for intravenous antibiotic therapy. She was admitted to the pediatric wad and started on therapy with oxacillin sodium. Cefotaxime was added to the treatment regime "for broader antibiotic coverage." The pt was diagnosed with multifocal cellulitis. During hospitalization, bone scan was performed twice, with negative results. Blood and urine cultures were negative. Echocardiogram was normal. The pt's WBC progressed as follows: 20; 19; 16; 11.4. In addition, ESR values progressed as follows: 92; 71; 107; 102 (04/07/2002). Additional lab findings included ANA<1:40, ASO 103 and CK 20. The pt's erythema and swelling resolved and she "defervesced" on intravenous antibiotic therapy. Subsequently, on 04/09/2002, the pt recovered and was discharged home, from the hospital, in "stable' condition. It was reported that she was bearing weight on discharged, "but .5cm bula." A follow-up appointment was scheduled with the physician on 04/12/2002. No further info is available.
Information has been received from a physician concerning a 33 year old Caucasian female who was vaccinated with her first dose of varicella vaccine on 3/12/96 and her second vaccine on 4/29/96. Subsequently, the pt learned she was pregnant (LMP approximately 4/8/96; estimated date of conception 4/22/96). Mitral valve prolapse and tachycardia were noted illnesses during pregnancy. The pt was also noted to have pregnancy induced hypertension. On 1/14/97 the pt delivered a normal, healthy female infant (7 lbs, 9 oz).  Follow up information received from he pt on 4/10/00 indicated "my daughter is fine, but since receiving the vax, I have been unable to carry another child. I have had three successive miscarriages since getting the vaccine. The three miscarriages occurred at 12, 10 and 12 weeks respectively." Additional information has been requested.  Follow-up dated 6/20/00 indicated that the pt questioned whether or not the miscarriages were related to therapy with varicella. The reporter responded "no" due to not being aware of a cause/effect relationship.
pt recv vax & w/in 24-48 hr post vax pt exp a flu-like synd;
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2013, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), by a physician, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On an unknown date later in 2013, the patient was treated by the physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Pt had PNEUMOVAX & FLUVIRIN vaccine administered 10/11/11 - pt reported on 10/14/11 with redness, swelling, soreness and possible streaking at injxn site both vaccines were admin in pts (L) arm.
The pt missed her scheduled appointment for COVID vaccine #2, so I called her to reschedule.  Today I reached her mother, who informed me that pt passed away last Tuesday.  I did not ask for any details of her death at this time.
Vaccination Complaint On 1/3/2020, I was administered the flublok quad injection by Nurse Practitioner in my upper right arm. I immediately began to experience severe pain but thought the pain would subside after a couple of days but the pain continued to worsen. About 3 weeks later, I became extremely ill and ended up taking off work for a couple of days due to effects of the shot. All total, I continued to be ill for 3 weeks while the pain in my right arm continued to worsen. As-a-matter-of-fact, by April, the pain had become severely worse. I did not visit the emergency room because the Corona virus was running its course and I didn't want to visit a hospital, nor did I have a primary care physician at the time.  Consequently, I decided to return to the Pharmacy Clinic to speak with whomever was working, and to my surprise, NP happened to be the person with whom I spoke.  I explained to her that I was having severe pain in my arm that was radiating from the spot of the injection, and up and down my arm and to my hand and fingers, causing numbness in my right hand and fingers. Today, I'm still having this issue but it appears as my left arm has also started to feel the same way. NP prescribed two drugs 1) celecoxib 200 MSG 2) diclofenac and 3) orphenadrine.  I began taking the muscle relaxer once I had purchased the prescription, but the pain continues, and it appears as though the weather is making the pain worse as of today.  When I wake up in the mornings, the fingers in both my right hand are numb, and my entire are feels numb from time to time, especially in the upper part of my right arm and shoulder. Also, there are times when the fingers in my left hand are numb too.  NP also provided me with paperwork about how to file a vaccination complaint with the agency, which I had never heard of until I began to experience adverse issues with the flu vaccination.
Arm swelling, redness/pain 3d prior to 2/1/16 visit.
Tingling sensation in left arm that radiated from injection site to hand, onset immediately after injection and lasted approximately 2 hours. Additionally, member noted  left sided inguinal pain; onset several hours after the injection. Pain described as an constant ache that lasted for 2 - 3 days. Member presented to medical department approximately 3 days after vaccination out of concern symptoms might be related to vaccination. Physical exam normal. Symptoms resolved on own without intervention.
got the first shot, didn't know about 2nd, it's now 8 months later; This case was reported by a consumer via  interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown day 8 month before reporting).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional information was provided as follows: The age at vaccination was not applicable for this report. The patient didin't knew about the 2nd shot. Till the time of reporting the patient did not receive the 2nd dose of vaccination which led to incomplete course of vaccination.
A rash all over the arm; a red area at the arm that is itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (A rash all over the arm) and PRURITUS (a red area at the arm that is itchy) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A.) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced RASH (A rash all over the arm) and PRURITUS (a red area at the arm that is itchy). At the time of the report, RASH (A rash all over the arm) and PRURITUS (a red area at the arm that is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
headache; This case was reported by a consumer via call center representative and described the occurrence of headache in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th July 2020, the patient received the 1st dose of Shingrix. On 30th July 2020, 1 days after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix and had headache. The reporter asked how long would headache last.
2 days pt  noticed sharp pain over collar bone, chest pain when breathing in, muscle aches and muscle aches. subsided in 4 days
pt devel some eczema on both deltoid areas the day p/got vax; mild redness;
A report was received from a health care professional on 10/29/2003 concerning a 52 year old female vaccinee who experienced injection site redness and warmth on the same day and itching eyes and ears 10 hours after receiving Fluvirin on 10/28/2003. The vaccinee had not recovered at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update1, 04/15/2004: A follow up report was received from a health care professional indicating that the vaccinee had recovered on an unspecified date. No follow up pending all information received. See Ref.: PJP200300945, PJP200300947, PJP200300948.
Feels like his chest is pounding. He stated that its almost like he has drunk a lot of coffee.
Narrative:  COVID infection following COVID vaccine series 02/24, Pfizer,  dose #1 003/19, Pfizer, dose #2 10/01,Pfizer, dose #3 12/24 SARS-COV-2  Variant Sequencing: pending 12/24 COVID swab, result: detected 12/23 pt cc:  cough, fatigue, headache, myalgias, rhinorrhea, sore throat exposure: unknown  12/28 abg: i-pH: 7.44 i-PC02: 46.5, i-P02: 70, i-HC03: 31.7 12/28 BNP: 45  12/28 pt admit ED, cc: shortness of breath and worsening cough, dx: COVID Viral  Syndrome LOS: 1 dav 01/03/22 clinically resolved
Swelling/soreness at injection site. Diarrhea beginning the morning after injection and lasting into the evening. Treated with over-the-counter medications (Ibuprofen and Imodium)